Jennifer Anne Brown (Jennifer A Brown)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 9

Top Topics

Positron Emission Tomography

Human Immunodeficiency Virus

Health Promotion

Top Venues

Open forum infectious diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Mathebe Kopo, Thabo Ishmael Lejone, Nadine Tschumi, Tracy Renée Glass, Mpho Kao, Jennifer Anne Brown, Olivia Seiler, Josephine Muhairwe, Ntoli Moletsane, Niklaus Daniel Labhardt, Alain Amstutz
Effectiveness of a peer educator-coordinated preference-based differentiated service delivery model on viral suppression among young people living with HIV in Lesotho: The PEBRA cluster-randomized trial. PLoS medicine 20 (1) (2023)
Mathebe Kopo, Thabo Ishmael Lejone, Nadine Tschumi, Tracy Renée Glass, Mpho Kao, Jennifer Anne Brown, Olivia Seiler, Josephine Muhairwe, Ntoli Moletsane, Niklaus Daniel Labhardt, Alain Amstutz
Effectiveness of a peer educator-coordinated preference-based differentiated service delivery model on viral suppression among young people living with HIV in Lesotho: The PEBRA cluster-randomized trial. PLoS medicine 20 (1) (2023)
Mathebe Kopo, Thabo Ishmael Lejone, Nadine Tschumi, Tracy Renée Glass, Mpho Kao, Jennifer Anne Brown, Olivia Seiler, Josephine Muhairwe, Ntoli Moletsane, Niklaus Daniel Labhardt, Alain Amstutz
Effectiveness of a peer educator-coordinated preference-based differentiated service delivery model on viral suppression among young people living with HIV in Lesotho: The PEBRA cluster-randomized trial. PLoS medicine 20 (1) (2023)
Mathebe Kopo, Thabo Ishmael Lejone, Nadine Tschumi, Tracy Renée Glass, Mpho Kao, Jennifer Anne Brown, Olivia Seiler, Josephine Muhairwe, Ntoli Moletsane, Niklaus Daniel Labhardt, Alain Amstutz
Effectiveness of a peer educator-coordinated preference-based differentiated service delivery model on viral suppression among young people living with HIV in Lesotho: The PEBRA cluster-randomized trial. PLoS medicine 20 (1) (2023)
Mathebe Kopo, Thabo Ishmael Lejone, Nadine Tschumi, Tracy Renée Glass, Mpho Kao, Jennifer Anne Brown, Olivia Seiler, Josephine Muhairwe, Ntoli Moletsane, Niklaus Daniel Labhardt, Alain Amstutz
Effectiveness of a peer educator-coordinated preference-based differentiated service delivery model on viral suppression among young people living with HIV in Lesotho: The PEBRA cluster-randomized trial. PLoS medicine 20 (1) (2023)
Jennifer Anne Brown, Anthony Hauser, Irene A Abela, Chloé Pasin, Selina Epp, Tsepang Mohloanyane, Bienvenu L Nsakala, Alexandra Trkola, Niklaus Daniel Labhardt, Roger D Kouyos, Huldrych F Gunthard
Seroprofiling of antibodies against endemic human coronaviruses and SARS-CoV-2 in an HIV cohort in Lesotho: correlates of antibody response and seropositivity. The Journal of infectious diseases (2023)
Jennifer Anne Brown, Bienvenu L Nsakala, Kuena Mokhele, Itumeleng Rakuoane, Josephine A Muhairwe, Tracy R Glass, Alain Amstutz, Nadine Tschumi, Jennifer M Belus, Thomas Klimkait, Niklaus Daniel Labhardt
Dolutegravir in real life: Self-reported mental and physical health outcomes after transitioning from efavirenz- to dolutegravir-based antiretroviral therapy in a prospective cohort study in Lesotho. HIV medicine (2022)
Nadine Tschumi, Malebanye Lerotholi, Mathebe Kopo, Mpho Kao, Blaise Lukau, Bienvenu Nsakala, Ntoiseng Chejane, Lipontso Motaboli, Tristan Lee, Ruanne V Barnabas, Adrienne E Shapiro, Alastair van Heerden, Thabo I Lejone, Alain Amstutz, Jennifer Anne Brown, Jesse Heitner, Jennifer M Belus, Frédérique Chammartin, Niklaus Daniel Labhardt
Assessment of a viral load result-triggered automated differentiated service delivery model for people taking ART in Lesotho (the VITAL study): Study protocol of a cluster-randomized trial. PloS one 17 (5) (2022)
Jennifer Anne Brown, Herbert A Mbunkah, Thabo Ishmael Lejone, Isaac Ringera, Molisana Cheleboi, Thomas Klimkait, Karin J Metzner, Huldrych F Gunthard, Niklaus Daniel Labhardt, Roger D Kouyos, Nadine Tschumi
Emergence of Human Immunodeficiency Virus-1 Drug Resistance During the 3-Month World Health Organization-Recommended Enhanced Adherence Counseling Period in the CART-1 Cohort Study. Open forum infectious diseases 8 (5) (2021)